As you might guess the molecules exhaled that are ripe for trace Mass Spec. diagnosis are not complex molecules. There certainly are complex molecules ripe for the "right" kind of Mass Spec analysis but just one friggin substantial partnership announcement by any trace detection mass spec company with any major company interested in medical trace diagnosis probably would increase the share price a bit. Uh, how long do you think it will be before AD is announced to be detectable via breath analysis? That statement bears repeating a few times. Uh, how long do think it will be before AD is announced to be detectable via breath analysis?
News 
Market Data 
Discover 
